Home / Recalls / Viatris Inc / D-0063-2023

D-0063-2023 Class II Terminated

Recalled by Viatris Inc — Canonsburg, PA

Recall Details

Product Type
Drugs
Report Date
November 23, 2022
Initiation Date
October 21, 2022
Termination Date
July 13, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,794 bottles

Product Description

Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05

Reason for Recall

Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: 3150116, Exp 2/2025

Other recalls by Viatris Inc

  • D-0204-2025 Class II — Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, (December 23, 2024)
  • D-0203-2025 Class II — Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, (December 23, 2024)
  • D-0119-2025 Class II — Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0124-2025 Class II — Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0127-2025 Class II — Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0128-2025 Class II — Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0125-2025 Class II — Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0123-2025 Class II — Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0126-2025 Class II — Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0121-2025 Class II — Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)